Astaxanthin Market to Expand at a Healthy Growth Rate in the Coming Years

The Astaxanthin Market is projected to reach USD 965 million by 2026, from USD 647 million in 2021, at a CAGR of 8.3% during the forecast period. Astaxanthin is recognized as the most powerful antioxidant in nature, wherein according to a 2019 report by NCBI, astaxanthin has established its benefits as a vital nutrient for human consumption. Its unique structure helps it to scavenge free radicals and protect the body against oxidative damage. Therefore, it is called super antioxidant. Apart from imparting antioxidant properties, astaxanthin is also beneficial to the eyes, heart, and skin, and has anti-cancer, anti-inflammatory, and anti-diabetic properties. Some of the key factors driving the growth of astaxanthin across the globe include beneficial effects on the healthcare sector, the growth of the end-user industries, and rising innovative technology developments for the extraction of astaxanthin.

Download PDF Brochure

The growing awareness about the health benefits of natural astaxanthin the demand for astaxanthin is expected to increase in the coming years.

Natural astaxanthin is primarily extracted from astaxanthin-containing marine plants, such as algae and biosynthesized, by living microalgae or yeast production. It is over 95% esterified and is 3.5 times more expensive as compared to synthetic astaxanthin. Natural astaxanthin is commonly preferred by the end-user industry as consumers are willing to spend more to get higher-quality products, and their harvest is usually done by centrifugation, drying, and cracking of the Haematococcus pluvialis cells.

Liquid form is projected to witness the highest growth during the forecast period.

Astaxanthin in the liquid form is used for manufacturing soft gels, oil extracts, and beadlets. Liquid astaxanthin finds various applications, such as syrups and texturing agents used in the food, beverage, and pharmaceutical industries. Liquid nutraceutical ingredients are difficult to use during scaling and temperature. However, astaxanthin in the liquid form is still used in various applications discussed above.

The microalgae cultivation segment, by method of production, is projected to be the fastest-growing at a CAGR of 9.4% during the forecast period.

The microalga H. Pluvialis is the richest source of astaxanthin. It contains 5% of dried H. pluvialis biomass, of which 90% comprises astaxanthin. The cultivation process consists of two stages—the green stage and the red stage. In the green stage, a single-cell colony of microalgae is allowed to grow unstressed by normal cell division. Optimal growth conditions are given to the “green” algal cells for maximum growth. In the second stage, cells are put through various stress conditions, such as high radiation intensity and changes in growth media. These conditions result in the production and accumulation of natural astaxanthin in the cells in the esterified form.

The Asia Pacific region dominated the astaxanthin market and is projected to grow at a significant CAGR of 8.4% by 2026.

The overall economic growth in the Asia Pacific region has led to an increase in urbanization and rapid industrialization. Hence, the consumption levels of astaxanthin differ from country to country and region to region. The increasing preference among consumers for healthy food and the high demand for meat and seafood are some of the major factors for the growth of animal feed applications of astaxanthin in the region. Asia Pacific offers great opportunities to manufacturers and suppliers of astaxanthin, owing to the cost advantage and high demand in this region.

Request for Customization

The key service providers in this market include Koninklijke DSM N.V. (the Netherlands), BASF SE (Germany), Cyanotech Corporation (US), Otsuka Holdings Co. Ltd. (Japan), Divi’s Laboratories Ltd. (India), Valensa International (US), Fuji Chemical Industries Co. Ltd. (Japan), Beijing Gingko Group (China), Cardax, Inc. (Denmark), Piveg, Inc (US), Fenchem Biotek Ltd. (China), Algatech Ltd. (Israel), Supreme Biotechnologies (New Zealand), Igene Biotechnology Inc. (US), Algamo (Czech Republic), Biogenic Co. Ltd. (Japan), Astamaz NZ Ltd. (New Zealand), Algalif (Iceland), Algae to Omega (US), and Algae Health Sciences (US).

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441